# RNAC (Cartesian Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Cartesian Therapeutics, Inc. reported $1.02M in revenue and a net loss of $127.5M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -15540.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/RNAC
- Markdown: https://convexityos.com/fundamentals/RNAC.md
- SEC CIK: 0001453687
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:44 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001453687&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $1.02M | -100.0% YoY |
| Operating Income | TTM | -$159.3M | -15540.9% margin |
| Net Income | TTM | -$127.5M | -12435.2% net margin |
| Diluted EPS | TTM | -$4.21 | Split-adjusted |
| Free Cash Flow | TTM | -$89.89M | -8770.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $123.0M | Total debt: $60.34M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.80M | $38.91M | $26.00M | $110.8M | $85.08M | $16.60M | $6.68M | $903K | $207K | $8.08M |
| Research & Development | $58.03M | $45.10M | $71.26M | $72.38M | $68.74M | $54.51M | $42.74M | $47.69M | $45.16M | $29.70M |
| Total Operating Expenses | $146.2M | $82.81M | $112.4M | $96.24M | $89.67M | $73.42M | $59.13M | $65.92M | $63.99M | $42.75M |
| **Operating Income** | -$143.4M | -$43.90M | -$86.42M | $14.54M | -$4.60M | -$56.82M | -$52.45M | -$65.02M | -$63.78M | -$34.67M |
| **EBITDA** | -$141.0M | -$42.70M | -$85.72M | $15.24M | -$4.00M | -$56.22M | -$51.76M | -$64.02M | -$63.03M | -$33.87M |
| Interest Income | $6.58M | $7.39M | $4.96M | -- | -- | -- | -- | -- | -- | -- |
| Interest Expense | -- | $0 | $2.83M | $3.03M | $2.84M | $1.56M | $1.52M | $1.49M | $1.21M | $1.25M |
| Income Before Tax | -$139.5M | -$77.14M | -$238.7M | $34.77M | -$9.72M | -$68.88M | -$55.35M | -- | -- | -- |
| Income Tax Expense | -$9.19M | $287K | -$19.00M | -$609K | $15.97M | $0 | $0 | -- | -- | -- |
| **Net Income** | -$130.3M | -$77.42M | -$219.7M | $35.38M | -$25.69M | -$68.88M | -$55.35M | -$65.34M | -$65.32M | -$36.21M |
| Basic EPS | -$5.02 | -$4.48 | -$49.76 | $7.21 | -$6.61 | -$20.42 | -$36.64 | -$87.69 | -$96.10 | -$116.82 |
| **Diluted EPS** | -$5.02 | -$4.49 | -$49.76 | $3.00 | -$6.61 | -$20.42 | -$36.64 | -$87.69 | -$96.10 | -$116.82 |
| Basic Shares Outstanding | 26.0M | 17.3M | 5.2M | 4.8M | 3.8M | 3.4M | 1.5M | 745.6K | 680.2K | 349.4K |
| Diluted Shares Outstanding | 26.0M | 17.4M | 5.2M | 4.9M | 3.8M | 3.4M | 1.5M | 745.6K | 680.2K | 349.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $78K | $947K | $452K | $298K | $1.10M | -$759K |
| Research & Development | $15.62M | $20.43M | $19.46M | $14.69M | $13.80M | $14.87M | $14.67M | $11.31M |
| Total Operating Expenses | $25.00M | $29.16M | $26.58M | $79.59M | $21.52M | $22.11M | $22.99M | $25.97M |
| **Operating Income** | -$25.00M | -$29.16M | -$26.50M | -$78.64M | -$21.07M | -$21.81M | -$21.89M | -$26.73M |
| **EBITDA** | -$24.20M | -$28.36M | -$25.90M | -$78.04M | -$20.47M | -$21.21M | -$21.29M | -$26.23M |
| Interest Income | $1.20M | $1.10M | $1.03M | $1.27M | $1.55M | $1.75M | $2.02M | -- |
| Interest Expense | $1.99M | $852K | -- | -- | $0 | $0 | -- | -- |
| **Net Income** | -$11.47M | $15.77M | -$39.18M | -$92.58M | -$35.90M | $15.89M | -$17.71M | -$10.25M |
| Basic EPS | -$0.38 | $0.47 | -$1.46 | -- | -$1.38 | $0.51 | -$0.68 | -- |
| **Diluted EPS** | -$0.38 | $0.46 | -$1.46 | -- | -$1.38 | $0.50 | -$0.68 | -- |
| Basic Shares Outstanding | 30.3M | 29.5M | 26.9M | -- | 26.0M | 26.0M | 25.9M | -- |
| Diluted Shares Outstanding | 30.3M | 29.9M | 26.9M | -- | 26.0M | 26.4M | 25.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $125.1M | $212.6M | $76.91M | $106.4M | $114.1M | $138.7M | $89.89M | $37.40M | -- | $70.62M |
| Short-Term Investments | -- | -- | $0 | $28.16M | $14.00M | $0 | -- | $0 | $25.94M | $25.94M |
| **Cash & Short-Term Investments** | $125.1M | $212.6M | $76.91M | $134.6M | $128.1M | $138.7M | $89.89M | $37.40M | -- | $96.56M |
| Accounts Receivable, Net | $1.11M | $872K | $5.87M | $6.60M | $9.91M | $7.22M | $5.00M | $0 | $63K | $63K |
| Other Current Assets | -- | -- | -- | -- | -- | -- | -- | $80K | -- | -- |
| **Total Current Assets** | $129.3M | $216.6M | $90.73M | $148.1M | $144.4M | $151.3M | $96.67M | $42.08M | $98.68M | $98.68M |
| Property, Plant & Equipment, Net | $12.19M | $9.91M | $2.11M | $2.79M | $2.14M | $1.40M | $1.22M | $2.13M | $2.09M | $2.09M |
| Goodwill | $48.16M | $48.16M | $48.16M | $0 | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | -- | $518K | $0 | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $167.1M | $218.4M | $214.3M | $17.75M | $15.44M | $14.09M | $2.90M | $2.41M | $2.42M | $2.42M |
| **Total Assets** | $296.4M | $435.0M | $305.1M | $165.9M | $159.9M | $165.4M | $99.57M | $44.48M | $101.1M | $101.1M |
| Accounts Payable | $1.29M | $288K | $3.15M | $316K | $224K | $443K | $500K | $1.10M | $1.61M | $1.61M |
| Deferred Revenue (Current) | -- | $0 | $2.31M | $593K | $53.88M | $72.05M | $1.67M | $959K | $787K | $787K |
| **Total Current Liabilities** | $14.94M | $22.98M | $68.21M | $25.08M | $72.25M | $81.55M | $34.94M | $35.14M | $10.97M | $10.97M |
| Long-Term Debt | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | $0 | $3.54M | $0 | $11.42M | $38.75M | $14.68M | $13.82M | $14.09M | $15.92M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | $0 | $938K | $1.20M | $1.20M |
| **Total Non-Current Liabilities** | $407.7M | $418.8M | $376.5M | $46.98M | $65.11M | $101.9M | $56.23M | $14.76M | $36.48M | $38.31M |
| **Total Liabilities** | $422.7M | $441.8M | $444.7M | $72.06M | $137.4M | $183.4M | $91.17M | $49.90M | $47.46M | $49.29M |
| **Total Debt (incl. Leases)** | $12.68M | $13.98M | $10.96M | $11.66M | $9.65M | $10.55M | $372K | -- | -- | -- |
| Common Stock | $3.0K | $3.0K | $1.0K | $15K | $12K | $11K | $9.0K | $3.0K | $3.0K | $3.0K |
| Retained Earnings | -$822.4M | -$692.1M | -$614.6M | -$394.9M | -$430.3M | -$404.6M | -$335.8M | -$280.4M | -$215.1M | -$216.9M |
| Accumulated Other Comp. Income | -$4.58M | -$4.62M | -$4.60M | -$4.56M | -$4.57M | -$4.56M | -$4.52M | -$4.56M | -$4.42M | -$4.42M |
| **Total Stockholders' Equity** | -$126.2M | -$6.80M | -$440.2M | $93.83M | $22.52M | -$18.01M | $8.40M | -$5.42M | $53.64M | $51.81M |
| Total Equity | -$126.2M | -$6.80M | -$440.2M | $93.83M | $22.52M | -$18.01M | $8.40M | -$5.42M | $53.64M | $51.81M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $123.0M | $147.6M | $118.6M | $125.1M | $143.4M | $160.3M | $180.4M | $212.6M |
| **Cash & Short-Term Investments** | $123.0M | $147.6M | $118.6M | $125.1M | $143.4M | $160.3M | $180.4M | $212.6M |
| Accounts Receivable, Net | $52K | $196K | $261K | $1.11M | $722K | $354K | $1.76M | $872K |
| **Total Current Assets** | $131.5M | $153.6M | $122.0M | $129.3M | $147.3M | $163.4M | $185.1M | $216.6M |
| Property, Plant & Equipment, Net | $10.73M | $11.31M | $11.64M | $12.19M | $12.39M | $12.29M | $10.17M | $9.91M |
| Goodwill | $48.16M | $48.16M | $48.16M | $48.16M | $48.16M | $48.16M | $48.16M | $48.16M |
| Other Non-Current Assets | -- | -- | -- | -- | -- | $5.55M | $6.05M | $518K |
| **Total Non-Current Assets** | $162.8M | $165.0M | $166.4M | $167.1M | $225.4M | $225.5M | $224.0M | $218.4M |
| **Total Assets** | $294.3M | $318.6M | $288.4M | $296.4M | $372.7M | $388.9M | $409.1M | $435.0M |
| Accounts Payable | $105K | $1.05M | $1.60M | $1.29M | $2.23M | $454K | $2.10M | $288K |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Liabilities** | $15.70M | $20.55M | $15.95M | $14.94M | $13.80M | $12.26M | $15.00M | $22.98M |
| Long-Term Debt | $50.22M | $52.85M | -- | $0 | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $409.1M | $423.3M | $420.6M | $407.7M | $394.7M | $379.2M | $415.9M | $418.8M |
| **Total Liabilities** | $424.8M | $443.9M | $436.5M | $422.7M | $408.5M | $391.4M | $430.9M | $441.8M |
| **Total Debt (incl. Leases)** | $60.34M | $63.85M | $11.86M | $12.68M | $12.60M | $13.35M | $14.07M | $13.98M |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K |
| Retained Earnings | -$857.3M | -$845.8M | -$861.6M | -$822.4M | -$729.8M | -$693.9M | -$709.8M | -$692.1M |
| Accumulated Other Comp. Income | -$4.62M | -$4.61M | -$4.58M | -$4.58M | -$4.59M | -$4.58M | -$4.59M | -$4.62M |
| **Total Stockholders' Equity** | -$130.5M | -$125.2M | -$148.1M | -$126.2M | -$35.84M | -$2.53M | -$21.79M | -$6.80M |
| Total Equity | -$130.5M | -$125.2M | -$148.1M | -$126.2M | -$35.84M | -$2.53M | -$21.79M | -$6.80M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$130.3M | -$77.42M | -$219.7M | $35.38M | -$25.69M | -$68.88M | -$55.35M | -$65.34M | -$65.32M | -$36.21M |
| Depreciation & Amortization | $2.40M | $1.20M | $700K | $700K | $600K | $600K | $700K | $1.00M | $750K | $802K |
| Stock-Based Compensation | $10.52M | $6.58M | $22.52M | $11.19M | $7.72M | $5.42M | $5.16M | $5.71M | $4.08M | $2.05M |
| Change in Receivables | -$243K | $5.00M | $726K | $3.32M | -$2.69M | -$2.22M | -$5.00M | $0 | $152K | $610K |
| Change in Payables | $1.07M | -$2.93M | $2.83M | $92K | -$219K | -$57K | -$600K | -$516K | -$2.33M | $2.69M |
| **Operating Cash Flow** | -$73.94M | -$23.67M | -$51.16M | -$31.63M | -$60.38M | $34.88M | -$51.44M | -$59.16M | -$52.03M | -$19.76M |
| Capital Expenditure | -$5.45M | -$9.09M | -$206K | -$1.20M | -$1.08M | -$815K | -$47K | -$884K | -$733K | -$586K |
| **Free Cash Flow** | -$79.39M | -$32.77M | -$51.37M | -$32.83M | -$61.47M | $34.07M | -$51.48M | -$60.05M | -$52.76M | -$20.34M |
| Purchases of Investments | -- | -- | $0 | -$33.50M | -$30.45M | $0 | -$18.19M | -- | -- | -- |
| Sales & Maturities of Investments | -- | -- | -- | -- | $16.40M | $0 | $18.34M | -- | -- | -- |
| **Investing Cash Flow** | -$5.45M | -$8.74M | $34.61M | -$15.00M | -$17.14M | -$741K | $229K | $25.27M | -$2.10M | -$22.10M |
| Common Stock Issued | -- | -- | -- | $2.12M | $51.96M | $2.11M | $30.94M | $0 | $10.00M | $2.74M |
| **Financing Cash Flow** | -$8.05M | $168.4M | -$13.14M | $39.22M | $52.90M | $14.43M | $105.0M | $697K | $66.02M | $67.66M |
| **Net Change in Cash** | -$87.41M | $136.0M | -$29.75M | -$7.40M | -$24.63M | $48.51M | $53.87M | -$33.34M | $11.98M | $26.27M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$11.47M | $15.77M | -$39.18M | -$92.58M | -$35.90M | $15.89M | -$17.71M | -$10.25M |
| Depreciation & Amortization | $800K | $800K | $600K | $600K | $600K | $600K | $600K | $500K |
| Stock-Based Compensation | $2.66M | $2.08M | $2.42M | $2.14M | $2.59M | $3.28M | $2.51M | $1.86M |
| Change in Receivables | $144K | $65K | $854K | -$393K | -$368K | $1.41M | -$893K | $3.96M |
| Change in Payables | -$720K | -$773K | $310K | -$933K | $1.77M | -$1.59M | $1.82M | -$237K |
| **Operating Cash Flow** | -$27.73M | -$21.08M | -$22.14M | -$17.71M | -$15.60M | -$17.52M | -$23.11M | -$7.00M |
| Capital Expenditure | -$441K | -$272K | -$27K | -$492K | -$1.29M | -$2.60M | -$1.07M | -$705K |
| **Free Cash Flow** | -$28.17M | -$21.35M | -$22.16M | -$18.20M | -$16.89M | -$20.12M | -$24.18M | -$7.71M |
| **Investing Cash Flow** | -$441K | -$272K | -$27K | -$492K | -$1.29M | -$2.60M | -$1.07M | -$354K |
| Common Stock Issued | $3.44M | $3.92M | $15.39M | -- | $0 | $0 | $0 | -- |
| **Financing Cash Flow** | $3.56M | $50.34M | $15.67M | -$52K | -$38K | $60K | -$8.03M | $783K |
| **Net Change in Cash** | -$24.63M | $28.96M | -$6.50M | -$18.25M | -$16.94M | -$20.04M | -$32.18M | -$6.59M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -5127.1% | -112.8% | -332.3% | 13.1% | -5.4% | -342.4% | -785.6% | -7200.7% | -30813.5% | -428.9% |
| **Net Profit Margin** | -4658.6% | -199.0% | -844.9% | 31.9% | -30.2% | -415.0% | -829.0% | -7235.4% | -31556.0% | -448.0% |
| Return on Equity (ROE) | -- | -- | -- | 37.7% | -114.1% | -- | -659.2% | -- | -126.1% | -65.9% |
| Return on Assets (ROA) | -44.0% | -17.8% | -72.0% | 21.3% | -16.1% | -41.6% | -55.6% | -146.9% | -64.6% | -40.5% |
| Current Ratio | 8.65x | 9.43x | 1.33x | 5.91x | 2.00x | 1.86x | 2.77x | 1.20x | 8.99x | 6.33x |
| Quick Ratio | 8.45x | 9.29x | 1.21x | 5.63x | 1.91x | 1.79x | 2.72x | 1.06x | 8.81x | 6.15x |
| Debt to Equity | -- | -- | -- | 0.12x | 0.43x | -- | 0.04x | -- | -- | -- |
| **Revenue Growth (YoY)** | -92.8% | +49.6% | -76.5% | +30.2% | +412.6% | +148.6% | +639.4% | +336.2% | -97.4% | +34.5% |
| Operating Income Growth (YoY) | -- | -- | -694.4% | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -721.0% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -790.4% | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -273.1% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -280.4% | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -97.8% | -48.8% | +315.3% | +7450.9% | -3.4% | -94.1% | -60.7% | -- | -- | -- |
| 10Y Revenue / Share Growth | -99.9% | -79.9% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -15540.9% | -10518.6% | -8338.9% | -5127.1% | -8386.5% | -8577.6% | -153.4% | -112.8% |
| **Net Profit Margin** | -12435.2% | -10283.8% | -8550.6% | -4658.6% | -4397.7% | -3534.1% | -112.1% | -199.0% |
| Return on Assets (ROA) | -43.3% | -47.7% | -52.6% | -44.0% | -12.9% | -9.3% | -9.4% | -17.8% |
| Current Ratio | 8.38x | 7.48x | 7.65x | 8.65x | 10.67x | 13.33x | 12.34x | 9.43x |
| Quick Ratio | 7.84x | 7.19x | 7.46x | 8.45x | 10.44x | 13.11x | 12.15x | 9.29x |
| **Revenue Growth (YoY)** | -100.0% | -100.0% | -92.9% | -- | +16.8% | -99.1% | -81.2% | -109.2% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -258.5% | -- | -- |
| **Net Income Growth (YoY)** | -- | -0.7% | -- | -- | -- | +14.8% | -- | -- |
| EPS Growth (YoY) | -- | -7.8% | -- | -- | -- | -12.1% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -213.9% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -325.5% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
